Reponses to topoisomerase-I inhibitors in extensive small-cell lung cancer: chance or chromosomes?
Perry
Michael C
MC
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000401:mortality; D002945:Cisplatin / Q000008:administration & dosage; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D059004:Topoisomerase I Inhibitors; D019772:Topotecan / Q000008:administration & dosage
D004791:Enzyme Inhibitors; D059004:Topoisomerase I Inhibitors; D005047:Etoposide; D019772:Topotecan; D002945:Cisplatin